Postdoctoral Fellow in Upper Gastrointestinal Cancer Translational Research

Located at Vall d’Hebron Institute of Oncology (VHIO), the Upper Gastrointestinal (GI) Cancer Translational Research Group serves as a vibrant center for pioneering clinical and translational researchers. Headed by Dr. Teresa Macarulla (MD PhD), our group operates in close collaboration, uniting clinical oncologists with the preclinical and translational team led by Dr. Tian Tian (MD PhD). Our collective dedication is unwavering, aimed at advancing pancreaticobiliary cancer research and seamlessly connecting laboratory breakthroughs with patient care.

We seek an enthusiastic postdoctoral fellow willing to participate in our translational project supported by the European Transcan-3 program. This project is at the interface of clinical and preclinical studies. The fellow will have the opportunity to work with many high-throughput techniques to study transcriptional, epigenetic, and metabolic dysregulations found in GI cancer patients (e.g., RNA-seq, ChIP-seq, ATAC-seq, MeDIP-seq, metabolomics) as well as the use of patient-derived preclinical models to perform drug screens ex vivo and in vivo. Moreover, we encourage the fellow to acquire bioinformatics competence for genome-wide data analysis. The fellow will work within an international consortium of groups from Spain, Germany, and Israel.

Skills/Qualifications
- Candidates must have obtained a PhD (biomedical-related areas) or an MD.
- Candidates who expect to be awarded a PhD or MD degree by December 2023 are eligible to apply.
- Outstanding academic record and at least one first-authored publication
- Open to candidates of any nationality.
- Candidates must have an excellent academic record and be the principal author of at least one peer-reviewed publication.
- Candidates must have a high working knowledge of English.

Specific Requirements
- Must have experience in molecular and cellular biology
- Skills in multi-omics experiments and analysis (e.g. RNA-seq, ChIP-seq, ATAC-seq, MeDIP-seq, and metabolomics) would be beneficial
Experience in translational research and hands-on work with mice would be a plus.

Start date: December 1st 2023